Enfusion (NYSE:ENFN) Stock Price Expected to Rise, Piper Sandler Analyst Says

Enfusion (NYSE:ENFN – Free Report) had its price objective lifted by Piper Sandler from $10.00 to $11.50 in a research note published on Monday morning,Benzinga reports. Piper Sandler currently has a neutral rating on the stock. Separately, Stifel Nicolaus upped their price objective on shares of Enfusion from $11.00 to $13.00 and gave the stock […]

Leave a Reply

Your email address will not be published.

Previous post Research Analysts Set Expectations for WGO Q3 Earnings
Next post CAE (NYSE:CAE) Upgraded at Desjardins